Mesoblast (MESO) Revenue (2016 - 2023)
Historic Revenue for Mesoblast (MESO) over the last 10 years, with Q2 2024 value amounting to -$10.3 million.
- Mesoblast's Revenue fell 58242.17% to -$10.3 million in Q2 2024 from the same period last year, while for Jun 2025 it was -$10.3 million, marking a year-over-year decrease of 6534.21%. This contributed to the annual value of $17.2 million for FY2025, which is 19139.27% up from last year.
- Per Mesoblast's latest filing, its Revenue stood at -$10.3 million for Q2 2024, which was down 58242.17% from $2.1 million recorded in Q2 2023.
- In the past 5 years, Mesoblast's Revenue registered a high of $12.2 million during Q1 2020, and its lowest value of -$10.3 million during Q2 2024.
- In the last 5 years, Mesoblast's Revenue had a median value of $2.0 million in 2022 and averaged $1.9 million.
- In the last 5 years, Mesoblast's Revenue skyrocketed by 107092.13% in 2020 and then tumbled by 58242.17% in 2024.
- Over the past 5 years, Mesoblast's Revenue (Quarter) stood at $2.2 million in 2020, then rose by 6.34% to $2.4 million in 2021, then dropped by 10.45% to $2.1 million in 2022, then grew by 0.23% to $2.1 million in 2023, then tumbled by 582.42% to -$10.3 million in 2024.
- Its Revenue was -$10.3 million in Q2 2024, compared to $2.1 million in Q2 2023 and $1.9 million in Q1 2023.